USG guided single point Lumbosacral plexus block is a newer approach for orthopaedic hip surgeries replacing General or spinal anesthesia with better intraoperative hemodynamics and postoperative analgesia

Ultrasound guided single injection Lumbosacral plexus blockade as effective mode of anesthesia for hip surgery - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086763

Enrollment

Registered

2025-05-13

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S720- Fracture of head and neck of femur Health Condition 2: S720- Fracture of head and neck of femur

Interventions

Intervention1: USG guided single point lumbosacral plexus block: USG guided single point lumbosacral plexus block of Inj. 0.5% Bupivacaine to the operating side for hip surgeries as sole anesthetic te

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective hip surgery 2. ASA 1, 2, 3 3. Patients willing to give informed written consent

Exclusion criteria

Exclusion criteria: 1. Age below 18 years 2. Lack of consent 3. Morbid obesity 4. Patients with coagulopathy and systemic infection 5. Local infection at injection site 6. Allergic to drug use 7. Pre existing chronic pain 8. Neurological deficit 9. Psychiatric illness

Design outcomes

Primary

Measure	Time frame
To study the intraoperative and postoperative effect of single point lumbosacral plexus block as anaesthetic and analgesic respectivelyTimepoint: To determine the duration of postoperative analgesia in first 24 hours at interval period of 2 hours	—

Secondary

Measure	Time frame
1. To assess the use of rescue analgesia 2. intraoperative opioid usage 3. intra operative hemodynamic status BP, Pulse rate and respiratory rate 4. Complications like Local anaesthetic toxicity, vascular injury 5. Postoperative nausea and vomitingTimepoint: In first 24 hours after surgery	—

Countries

India

Contacts

Public ContactDr C Vairavarajan MD

Madurai Medical College

drvairav@yahoo.co.in9842190336

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026